- Home
- KLRS vs NAMM Comparison
KLRS vs NAMM Comparison
Compare KLRS & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRS | NAMM |
|---|---|---|
| Founded | 2019 | 2024 |
| Country | United States | Cayman Islands |
| Employees | 20 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 123.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KLRS | NAMM |
|---|---|---|
| Price | $4.94 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | 82.7K | ★ 409.5K |
| Earning Date | 05-13-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $76.84 |
| Revenue Next Year | N/A | $85.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.14 | $0.91 |
| 52 Week High | $11.88 | $27.78 |
Technical Indicators
Market Signals| Indicator | KLRS | NAMM |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 32.68 |
| Support Level | $4.35 | $1.29 |
| Resistance Level | $5.38 | $1.80 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 38.18 | 14.77 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About NAMM Namib Minerals Ordinary Shares
Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.